DP
REPL icon

Diadema Partners’s Replimune Group REPL Stock Holding History

Diadema Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.52M Buy
+459,900
New +$3.52M 0.6% 45

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Diadema Partners's REPL Position: Q1 2026 in Review

Diadema Partners reduced its Replimune Group (REPL) stake by 56% in Q1 2026, selling an estimated $996K and leaving 100,660 shares worth $770K. The position accounts for 0.13% of the portfolio, ranked #93.

Diadema Partners first reported a position in REPL in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.25M in Q4 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Diadema Partners held 100,660 shares of Replimune Group worth $770K as of Q1 2026.
  • Diadema Partners sold 130,337 Replimune Group shares in Q1 2026, an estimated $996K.
  • Replimune Group made up 0.13% of Diadema Partners's portfolio in Q1 2026, its #93 holding.
  • Diadema Partners first reported a position in Replimune Group in Q4 2024 and has held it in 5 quarters since.
  • Diadema Partners's Replimune Group position peaked at $2.25M in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Diadema Partners's 13F filing for Q1 2026, filed 15 May 2026.